ARVN vs VRTX: Which Stock is Better?
Side-by-side comparison of Arvinas Inc and Vertex Pharmaceuticals Inc in 2026
ARVN
Arvinas Inc
$8.98
VRTX
Vertex Pharmaceuticals Inc
$447.54
Key Metrics Comparison
| Metric | ARVN | VRTX | Winner |
|---|---|---|---|
| Market Cap | $579.40M | $113.59B | VRTX |
| P/E Ratio | N/A | 26.53 | VRTX |
| EPS (TTM) | $N/A | $16.87 | VRTX |
| Revenue Growth | -0.9% | 0.1% | VRTX |
| Gross Margin | 134.5% | 54.4% | ARVN |
Analyze ARVN
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARVN or VRTX a better investment?
Comparing ARVN and VRTX: Arvinas Inc has a market cap of $579.40M while Vertex Pharmaceuticals Inc has $113.59B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARVN and VRTX?
ARVN (Arvinas Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARVN or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ARVN or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.9% for ARVN.
Which company is more profitable: ARVN or VRTX?
Arvinas Inc (ARVN) has higher gross margins at 134.5% compared to 54.4% for VRTX.
Which is the larger company: ARVN or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.59B compared to $579.40M for ARVN.
Should I buy ARVN or VRTX in 2026?
Both ARVN and VRTX have investment merit. ARVN trades at $8.98 while VRTX trades at $447.54. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARVN and VRTX stock?
Key differences: Market Cap ($579.40M vs $113.59B), P/E Ratio (N/A vs 26.5x), Revenue Growth (-0.9% vs 0.1%), Gross Margin (134.5% vs 54.4%).